Pharmacist-led HIV and hepatitis C point-of-care testing and risk mitigation counseling in individuals experiencing homelessness

Kherghehpoush, Sorosh; McKeirnan, Kimberly C.

doi:10.1016/j.rcsop.2021.100007

Cited by 8 publications

(6 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This study showed that participants complied with pharmacist-provided screening point-of-care services within a CP. This study concluded that comprehensive patient-centered PhC education and risk mitigation counseling might lower virus transmission rates among community individuals 53 (Table 3).…”

Section: Counseling and Patient Education Within Community Pharmaciesmentioning

confidence: 90%

“…The service proved sustainable during the Coronavirus Pandemic Disease (COVID-19) when the healthcare system was not functioning at its standard capacity (Table 5). 65 Another POCT study was conducted by Kherghehpoush and McKeirnan (2021) in the USA within a community pharmacy specializing in mental health services and serving people experiencing homelessness. The study assessed the health impacts of pharmacist-led HIV and HCV screening linked with education and risk mitigation counseling.…”

Section: Health Promotion and Immunizationmentioning

confidence: 99%

See 1 more Smart Citation

Outcomes of Pharmacist-Led Pharmaceutical Care Interventions Within Community Pharmacies: Narrative Review

Eldooma¹,

Maatoug²,

Yousif³

2023

IPRP

View full text Add to dashboard Cite

Pharmaceutical care (PhC) services interventions led by pharmacists within community pharmacies (CPs) are essential in achieving optimal medication use outcomes. PhC is a concept related to medication use goals optimization through the reduction and prevention of drug-related problems (DRPs). This review paper summarized the literature on pharmacist-led PhC interventions within CPs. PubMed and Google Scholar publications were searched, identified, and summarized. Results showed that some studies handled community pharmacists' roles, and some talked about PhC interventions. However, some studies reviewed the use of medicines, adherence, and follow-up, while other groups were on counseling, patient education, and health promotion. Pharmacists integrated some studies concerning diagnosis and disease screening into community pharmacy services. Besides these studies, there were studies on system design and installation of PhC service models. Most of the identified research results showed pharmacist-led intervention benefits for patients. These benefits include reduced DRPs, clinical, economical, humane, education and knowledge, disease prevention and immunization, identification of practice process problems, and the need for current practice redesigning. In conclusion, pharmacists can help patients achieve optimal outcomes through pharmacist-led interventions. Despite mentioned results, We recommend researching comprehensively applied PhC services provision models within CPs for more pharmacists-led interventions and role activation.

show abstract

Section: Counseling and Patient Education Within Community Pharmaciesmentioning

confidence: 90%

Section: Health Promotion and Immunizationmentioning

confidence: 99%

Outcomes of Pharmacist-Led Pharmaceutical Care Interventions Within Community Pharmacies: Narrative Review

Eldooma¹,

Maatoug²,

Yousif³

2023

IPRP

View full text Add to dashboard Cite

show abstract

“…While the currently described roles are important activities and acute care pharmacists are well positioned to optimize the medication use process related to OUD interventions, the literature describing outpatient pharmacist activities abounds with examples that should also be explored in the acute care setting. Examples include pharmacist-led programs to improve commonly co-occurring infectious disease screening 29,30 and complex medication management. 31 The pharmacist-led pain consult team 24 provides a unique example that could be expanded into other domains, including pharmacist-led psychiatric and infectious diseases consult services.…”

Section: Discussionmentioning

confidence: 99%

Role of the pharmacist in acute care interventions for opioid use disorder: A scoping review

Irwin

Walkerly

2021

J Am Coll Clin Pharm

View full text Add to dashboard Cite

Opioid use disorder (OUD) is associated with significant morbidity and mortality in the United States. In recent years, interest in initiatives to increase access to medication for OUD (MOUD) and overdose-reversing medications (naloxone) in acute care has grown. While well positioned to intervene, the role of acute care pharmacists in these interventions is not known. The objective for this scoping review was to better understand what is presently known about the role of pharmacists in acute care OUD interventions. These were defined as initiatives implemented in either inpatient or emergency department (ED) settings aimed at treatment of OUD (eg, initiation or management of MOUD) or harm reduction in individuals with OUD (eg, education or targeted naloxone dispensing). PubMed/MEDLINE and Embase databases were searched for articles pertaining to the research question from inception to 19 May 2021. Pearling was performed after the identification of eligible articles. Articles had to explicitly describe the pharmacist's role in planning, implementing, or evaluating an OUD intervention in the inpatient or ED setting.Data charting was performed by both authors using a predefined template, and data synthesis was performed via discussion between authors. The initial title search yielded 101 references which were screened and resulted in four articles that met inclusion criteria. Three additional articles were identified in the pearling process, yielding a total of seven articles. Four described initiatives aimed at point-ofcare dispensing of naloxone, and three described initiatives for provision or management of MOUD. Pharmacist roles primarily consisted of medication use process management, hospital staff and patient education, and dispensing activities. Literature describing the role of pharmacists in acute care OUD interventions is limited.Given the burden of OUD, there are many opportunities for further exploration of the roles acute care pharmacists can play in OUD harm reduction and treatment.

show abstract

“…Various studies recognize community pharmacies as vital in providing education to patients who seek screening. 38,36,39 Isho et al 38 noted that screening provided an opportunity to increase patients' knowledge and awareness about hepatitis C. Those who were screened were provided with education about what hepatitis C was, how it spread, and how it was treated. Another program also educated patients on up-to-date evidence-based screening strategies for hepatitis C. 36 Increasing patient's knowledge and awareness about hepatitis increases the willingness to uptake screening.…”

Section: Role Of Community Pharmacies In Hepatitis Screeningmentioning

confidence: 99%

Hepatitis Screening in Community Pharmacies as a Measure of Reducing the Rate of Infections

Dave

2024

J. Drug Delivery Ther.

View full text Add to dashboard Cite

The burden of dealing with HBV and HCV still remain despite the progress that has been made in screening, vaccination, and treating the infections. On average, there about 354 million cases of hepatitis globally. Hepatitis has high mortality rates. On average, 1.1 million people lose their lives to the infections each year. Addressing hepatitis requires rigorous measures one of them being increasing screening. Hepatitis infections are identified through screening. As such, screening and taking the right preventative and treatment measures can help to reduce the risk of infections. However, screening is still a challenge. The number of people who screen for hepatitis remains low despite the efforts that have been put in place to increase uptake. The uptake of screening is low because of inadequate access to screening centers. Thus, increasing screening settings can help to increase uptake. Community pharmacies can help to bridge this barrier by making screening more accessible. They are accessible and in close proximity to vulnerable populations, which makes them ideal as screening settings. This review explores the potential of community pharmacies as screening settings for HBV and HCV and whether they can help to reduce the rate of infections. Keywords: screening, hepatitis B, hepatitis C, community pharmacies

show abstract

Pharmacist-led HIV and hepatitis C point-of-care testing and risk mitigation counseling in individuals experiencing homelessness

Cited by 8 publications

References 18 publications

Outcomes of Pharmacist-Led Pharmaceutical Care Interventions Within Community Pharmacies: Narrative Review

Outcomes of Pharmacist-Led Pharmaceutical Care Interventions Within Community Pharmacies: Narrative Review

Role of the pharmacist in acute care interventions for opioid use disorder: A scoping review

Hepatitis Screening in Community Pharmacies as a Measure of Reducing the Rate of Infections

Contact Info

Product

Resources

About